Fumarsaeure-isopropylester-methylester | 80652-48-8

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: Fumarsaeure-isopropylester-methylester
• 英文别名: 1-O-methyl 4-O-propan-2-yl (E)-but-2-enedioate
• CAS: 80652-48-8
• 化学式: C₈H₁₂O₄
• 分子量: 172.181
• InChiKey: WQIXPEFEGKBHTP-SNAWJCMRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  12
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  甲醇 、 (E)-4-isopropoxy-4-oxo-2-butenoic acid chloride 在 吡啶 作用下， 生成 Fumarsaeure-isopropylester-methylester
  参考文献：
  名称：

  Notes- The Preparation of i-Propyl Cyanomethyl Fumarate

  摘要：

  DOI：

  10.1021/jo01081a608

文献信息

• CURATIVES FOR EPOXY ADHESIVE COMPOSITIONS
  申请人：Dershem Stephen M.

  公开号：US20100113643A1

  公开（公告）日：2010-05-06

  The invention provides epoxy and oxetane compositions including the novel acyloxy and N-acyl curing agents described herein. Use of invention curing agents result in cured adhesive compositions with remarkably increased adhesion and reduced hydrophilicity when compared to resins cured with other types of curing agents. Furthermore, the curatives of this invention do not interfere with free-radical cure and are thus suited for use in hybrid cure thermoset compositions.

  该发明提供了包括新型酰氧基和N-酰基固化剂的环氧树脂和氧环烷组合物。使用该发明的固化剂可使胶粘剂组合物固化后的粘附性大大增加，并且与用其他类型的固化剂固化的树脂相比，其亲水性减少。此外，该发明的固化剂不会干扰自由基固化，因此适用于混合固化热固性组合物的使用。
• OXABICYCLOHEPTANE PRODRUGS
  申请人：KOVACH JOHN S.

  公开号：US20160333024A1

  公开（公告）日：2016-11-17

  The present invention provides a compound having the structure:

  本发明提供了一种具有以下结构的化合物：
• METHODS OF ADMINISTERING MONOMETHYL FUMARATE AND PRODRUGS THEREOF HAVING REDUCED SIDE EFFECTS
  申请人：XenoPort, Inc.

  公开号：US20150038499A1

  公开（公告）日：2015-02-05

  Methods of improving patient safety and reducing undesirable side effects for patients considering therapeutic treatment using monomethyl fumarate and prodrugs of monomethyl fumarate are disclosed. In particular, a method of treating a disease in a patient in need of such treatment is provided. The method comprises testing the patient for a propensity for a deficiency in tissue glutathione S-transferase theta 1 enzyme (GSTT1) levels. Thereafter, a therapeutically effective amount of a compound selected from monomethyl fumarate (MMF), a prodrug of monomethyl fumarate, and combinations thereof is administered to the patient. During the treatment of the disease, blood lymphocyte concentration is periodically tested in the patient at a predetermined time interval length that is based on the enzyme level propensity testing result.

  本发明涉及改善患者安全和减少治疗使用单甲基富马酸及其前药所产生的不良副作用的方法。具体而言，本发明提供了一种治疗患者疾病的方法。该方法包括对患者进行组织谷胱甘肽S-转移酶θ1酶（GSTT1）水平缺陷的倾向性测试。随后，向患者施用单甲基富马酸（MMF）、单甲基富马酸前药或其组合的治疗有效量。在治疗疾病期间，以基于酶水平倾向性测试结果的预定时间间隔长度定期检测患者的血淋巴细胞浓度。
• CURATIVES FOR EPOXY COMPOSITIONS
  申请人：Dershem Stephen M.

  公开号：US20100249276A1

  公开（公告）日：2010-09-30

  The invention provides epoxy and oxetane compositions including the novel acyloxy and N-acyl curing agents described herein. Use of invention curing agents result in cured adhesive compositions with remarkably increased adhesion and reduced hydrophilicity when compared to resins cured with other types of curing agents. Furthermore, the curatives of this invention do not interfere with free-radical cure and are thus suited for use in hybrid cure thermoset compositions.

  本发明提供了环氧和氧杂环烷组分，包括本文所述的新型酰氧基和N-酰基固化剂。使用本发明的固化剂可使固化的粘合剂组分具有显著增强的粘附性和降低的亲水性，与使用其他类型固化剂固化的树脂相比。此外，本发明的固化剂不干扰自由基固化，因此适用于混合固化热固性组分的使用。
• CURATIVES FOR EPOXY COMPOSITIONSERS
  申请人：Designer Molecules, Inc.

  公开号：US20130299747A1

  公开（公告）日：2013-11-14

  The invention provides epoxy and oxetane compositions including the novel acyloxy and N-acyl curing agents described herein. Use of invention curing agents result in cured adhesive compositions with remarkably increased adhesion and reduced hydrophilicity when compared to resins cured with other types of curing agents. Furthermore, the curatives of this invention do not interfere with free-radical cure and are thus suited for use in hybrid cure thermoset compositions.

  本发明提供了环氧和氧杂环戊烷组合物，其中包括所述的新型酰氧基和N-酰基固化剂。使用本发明的固化剂可使固化粘合剂组合物的粘附性显著增加，并且与使用其他类型的固化剂固化的树脂相比，水亲和性降低。此外，本发明的固化剂不会干扰自由基固化，因此适用于混合固化热固性组合物的使用。